HMGB1 and cancer: After treatment with these drugs, cancer cells release DAMPs, which include HMGB1 from the nucleus, the translocation of CRT from the endoplasmic reticulum to the cell surface, and ATP secreted into the extracellular medium, promoting their recognition by immune cells [62].